We are a stem cell company specializing in induced pluripotent stem cell (iPSC)-based platforms for rare neurological diseases.

Founded at ODTÜ Teknokent with the support of the TÜBİTAK BİGG fund (TEYDEB 1812), TiPS Cell set out to make a difference in the field of medical biotechnology.

About Us

Our Mission

TiPS Cell provide high-quality, high efficiency induced pluripotent stem cell (iPSC)-based models to researchers for disease modeling, drug screening and regenerative medicine research.

Our research team, bringing years of experience in iPSC reprogramming, generates induced pluripotent stem cell (iPSC)-based disease models for rare neurological diseases and utilizes these platforms to develop innovative small-molecule drugs, cell therapies, and gene therapies.